Guardant Health (GH) Operating Expenses (2017 - 2026)

Guardant Health has disclosed Operating Expenses across 10 years of filings, most recently posting $423.0 million for Q1 2026.

• Operating Expenses for Q1 2026 came in at $423.0 million, up 34.5% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.5 billion (up 24.32% YoY), and the FY2025 annual result was $1.4 billion, up 20.01% from the prior year.
• Operating Expenses came in at $423.0 million for Q1 2026 at Guardant Health, up from $402.1 million in the prior quarter.
• In the past five years, Operating Expenses ranged from a high of $423.0 million in Q1 2026 to a low of $219.4 million in Q1 2022.
• The 5-year median for Operating Expenses is $277.9 million (2024), against an average of $302.8 million.
• Across the five-year window, Operating Expenses declined 7.03% in 2024 and jumped 34.5% in 2026, its largest moves.
• Guardant Health's Operating Expenses stood at $273.0 million in 2022, then climbed by 29.14% to $352.6 million in 2023, then declined by 7.03% to $327.8 million in 2024, then advanced by 22.67% to $402.1 million in 2025, then advanced by 5.21% to $423.0 million in 2026.
• The last three Operating Expenses figures came in at $423.0 million (Q1 2026), $402.1 million (Q4 2025), and $364.2 million (Q3 2025), per Business Quant data.